ATXI
What one share of Avenue Therapeutics holds
Pharmaceutical Preparations
Avenue Therapeutics, Inc. (“Avenue” or the “Company”) is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases.
Avenue Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.86 |
| Cash and investments | $0.59 |
| Book value | $0.17 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$16.66 | — | −$8.56 | — | −$37.98 |
| 2017 | — | −$27.71 | — | −$15.38 | — | $28.32 |
| 2018 | — | −$31.57 | — | −$26.69 | — | −$0.89 |
| 2019 | — | −$24.72 | — | −$25.05 | — | $6.11 |
| 2020 | — | −$4.68 | — | −$4.19 | — | $2.11 |
| 2021 | — | −$3.29 | — | −$3.31 | — | $2.45 |
| 2024 | $0.00 | −$9.00 | — | −$6.97 | — | $1.33 |
| 2025 | $0.45 | −$0.93 | — | −$0.59 | — | $0.58 |